Article ; Online: Methylation of lncSHGL promotes adipocyte differentiation by regulating miR-149/Mospd3 axis.
2024 Volume 22, Issue 21-22, Page(s) 2361–2380
Abstract: Obesity poses significant health risks and can negatively impact an individual's quality of life. The human obesity phenotype results from the differentiation of pre-adipocytes into adipocytes, which leads to hypertrophy and hyperplasia in adipose tissue. ...
Abstract | Obesity poses significant health risks and can negatively impact an individual's quality of life. The human obesity phenotype results from the differentiation of pre-adipocytes into adipocytes, which leads to hypertrophy and hyperplasia in adipose tissue. The molecular mechanisms by which long non-coding RNAs (lncRNAs) modulate adipocyte differentiation, a process implicated in obesity development, remain poorly characterized. A lncRNA which suppressed the hepatic gluconeogenesis and lipogenesis (lncSHGL) was newly identified. Our research aims to elucidate the functional role and mechanistic underpinnings of suppressor of lncSHGL in adipocyte differentiation. We observed that lncSHGL expression progressively diminished during 3T3-L1 differentiation and was downregulated in the liver and perirenal adipose tissue of ob/ob mice. lncSHGL acts as a molecular sponge for miR-149, with Mospd3 identified as a target of miR-149.Overexpression of lncSHGL and inhibition of miR-149 led to suppressed 3T3-L1 proliferation, decreased lipid droplet accumulation, and attenuated promoter activity of PPARγ2 and C/EBPα. These changes consequently resulted in reduced expression of Cyclin D1, LPL, PPARγ2, AP2, and C/EBPα, as well as inhibited the PI3K/AKT/mTOR signaling pathway. In contrast, lncSHGL suppression yielded opposing outcomes. Moreover, the effects of lncSHGL overexpression and miR-149 inhibition on reduced expression of Cyclin D1, LPL, PPARγ2, AP2, and C/EBPα were reversible upon miR-149 overexpression and Mospd3 suppression. These findings were further validated |
---|---|
MeSH term(s) | Animals ; Humans ; Mice ; 3T3-L1 Cells ; Adipocytes/metabolism ; Adipogenesis/genetics ; CCAAT-Enhancer-Binding Protein-alpha/genetics ; CCAAT-Enhancer-Binding Protein-alpha/metabolism ; CCAAT-Enhancer-Binding Protein-alpha/pharmacology ; Cell Differentiation ; Cyclin D1/metabolism ; Methylation ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Obesity/genetics ; Obesity/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; PPAR gamma/metabolism ; Quality of Life |
Chemical Substances | CCAAT-Enhancer-Binding Protein-alpha ; Cyclin D1 (136601-57-5) ; MicroRNAs ; MIRN149 microRNA, human ; Phosphatidylinositol 3-Kinases (EC 2.7.1.-) ; PPAR gamma ; MIRN149 microRNA, mouse |
Language | English |
Publishing date | 2024-01-18 |
Publishing country | United States |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2146183-1 |
ISSN | 1551-4005 ; 1538-4101 ; 1554-8627 |
ISSN (online) | 1551-4005 |
ISSN | 1538-4101 ; 1554-8627 |
DOI | 10.1080/15384101.2023.2287367 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5881: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.